Innoviva, Inc.
USD21.58
+0.30 (+1.41%)
CEO
Pavel Raifeld
IPO Date
2004-10-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$21.35
Prev. Close
$21.28
Day Low
$21.19
Day High
$21.73
52W Low
$16.52
52W High
$25.15
Market Cap
$1.59B
Volume
0.59M
| 559 |
| $22.24 |
| 22 May 2026 | Raifeld Pavel | director, officer: Chief Executive Officer | A-Award | Acquired | 1,123 | $0.00 |
| 22 May 2026 | Raifeld Pavel | director, officer: Chief Executive Officer | F-InKind | Disposed | 1,130 | $22.24 |
| 22 May 2026 | Zhen Marianne | Chief Accounting Officer | F-InKind | Disposed | 1,127 | $22.24 |
| 20 May 2026 | Linden Josephine | director | A-Award | Acquired | 5,733 | $0.00 |
| 20 May 2026 | Linden Josephine | director | A-Award | Acquired | 9,461 | $0.00 |
| 20 May 2026 | Linden Josephine | director | A-Award | Acquired | 9,166 | $21.80 |
| 20 May 2026 | Linden Josephine | director | Disposed | 0 | $0.00 |
| 6 May 2026 | DiPaolo Mark | director | A-Award | Acquired | 9,786 | $0.00 |